Although Eisai decided not to option a HER2-targeted drug under a deal with BlissBio, Angle wants to keep working with the firms to advance its CTC technology.

LCGC International spoke with Daniel Meston and Dwight Stoll from Gustavus Adolphus College in St. Peter, Minnesota, USA, ...

Pancreatic cancer is another disease that could benefit from a blood-based diagnostic test. Unlike colon cancer, pancreatic ...

Great recipes require the perfect combination of ingredients—biotechnology recipes are no exception. Researchers from Osaka ...

A consortium of Austrian research groups from the University of Vienna, MedUni Vienna and Technikum Wien, together with ...

Sleek, simple, vegan, and sustainable. Sounds great, right? That’s exactly what I thought when I recently went online in ...

Only recently has the ribosome - one of the oldest molecular machines in evolutionary terms - been recognized as an active regulator of gene expression at the level of protein biosynthesis.

Learn more about whether Repligen Corporation or Bio-Techne Corporation is a better investment based on AAII's A+ Investor ...

In the first day of the trial in a lawsuit to stop the renovation of a historic stadium in Franklin Park, attorneys for the ...

The artist’s mid-career retrospective at the Barnes Foundation is a testament to her relentless confrontation of the history ...

Brandon Winkler felt a little uncomfortable, he said, when he was asked to lead worship on a Sunday morning in Brasilia, ...

U.S. inflation data for February will be the highlight among economic data as investors continue to follow the back-and-forth of U.S. President Trump’s announcements on tariffs. A rate decision ...